Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TP53 | P04637 | 4/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL30200325 | 0.97 | TSHR (0.44) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL316282 | 0.94 | TSHR (0.44) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL14362184 | 0.93 | TSHR (0.42) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL459213 | 0.93 | TSHR (0.42) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| 1,6-Hexanediol SCHEMBL8212859 | 0.92 | TSHR (0.43) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL8664308 | 0.91 | TSHR (0.41) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL8516311 | 0.91 | TSHR (0.41) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL1173477 | 0.88 | MAPT (0.45) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL6275938 | 0.88 | TSHR (0.39) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Acrylic Acid Ethyl Ester SCHEMBL3278000 | 0.88 | TSHR (0.42) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4791732-B2 | — | — | 2011-10-12 | — | — | JP | claimed |
| EP-1583803-B1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | BASF SE (DE) | 2010-07-28 | — | — | EP | claimed |
| EP-1583803-A1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | Ciba SC Holding AG (CH) | 2005-10-12 | — | — | EP | claimed |
| US-6867301-B2 | Oxidation process for highly dispersible quinacridone pigments | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-03-15 | — | — | US | claimed |
| WO-2004063284-A1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-07-29 | — | — | WO | claimed |
| US-20040138458-A1 | Oxidation process for highly dispersible quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-15 | — | — | US | claimed |
| US-4804531-A | Cosmetic screening composition containing a UV screen in combination with a polymer obtained by block polymerization in emulsion and its use for the protection of the human epidermis against ultraviolet radiations | L'OREAL (FR) | 1989-02-14 | — | — | US | claimed |
| EP-1583803-B1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | BASF SE (DE) | 2010-07-28 | — | — | EP | disclosed |
| EP-1583803-A1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | Ciba SC Holding AG (CH) | 2005-10-12 | — | — | EP | disclosed |
| US-6867301-B2 | Oxidation process for highly dispersible quinacridone pigments | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-03-15 | — | — | US | disclosed |
| WO-2004063284-A1 | OXIDATION PROCESS FOR PREPARING HIGHLY DISPERSIBLE QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-07-29 | — | — | WO | disclosed |
| US-20040138458-A1 | Oxidation process for highly dispersible quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-15 | — | — | US | disclosed |
| US-6726758-B2 | CARBON BLACK, A MAGENTA PIGMENT, AND A CYAN PIGMENT AS COLORANTS, AND THE PLURALITY OF BLACK INK COMPOSITIONS ARE DIFFERENT FROM EACH OTHER IN CONTENT OF CARBON BLACK, AND THE CONTENT OF THE MAGENTA PIGMENT | SEIKO EPSON CORPORATION (JP) | 2004-04-27 | — | — | US | disclosed |
| US-20030056687-A1 | Black ink set and recording method using the same | SEIKO EPSON CORPORATION | 2003-03-27 | — | — | US | disclosed |
| US-6440203-B2 | WATER SOLUBILITY | SEIKO EPSON CORPORATION (JP) | 2002-08-27 | — | — | US | disclosed |
| US-20010035110-A1 | Ink composition capable of realizing images possessing excellent color development and fixation | SEIKO EPSON CORPORATION | 2001-11-01 | — | — | US | disclosed |
| EP-1114851-A1 | Ink composition capable of realizing images possessing excellent color development and fixation | SEIKO EPSON CORPORATION (JP) | 2001-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138458-A1 | Oxidation process for highly dispersible quinacridone pigments | NDUFA6, NDUFS6, NDUFA3 | TSHR 4164/4885ALDH1A1 88/4885TP53 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.